临床试验发现 Tecovirimat 尽管安全，但对治疗进化枝 II 猴痘无效。 Clinical trial finds Tecovirimat ineffective for treating clade II monkeypox, despite being safe.

一项国际临床试验发现，用于治疗天花的药物 Tecovirimat 是安全的，但对治疗猴痘进化枝 II 毒株无效。 An international clinical trial found that Tecovirimat, a drug used to treat smallpox, is safe but ineffective for treating the clade II strain of monkeypox. 这项由 NIH 赞助并在多个国家进行的试验显示，Tecovirimat 和安慰剂之间的结果没有显着差异。 The trial, sponsored by the NIH and conducted in multiple countries, showed no significant difference in outcomes between Tecovirimat and a placebo. 研究人员强调需要探索进化枝 II 猴痘的替代疗法。 Researchers emphasize the need to explore alternative treatments for clade II monkeypox.